
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Harm reduction measures in a recreational gym user with anabolic androgenic steroid dependence: a case report in the context of current best clinical practice - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E4A83B8AF2833305A83B000399F354.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="harmred">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369084/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Harm Reduction Journal">
<meta name="citation_title" content="Harm reduction measures in a recreational gym user with anabolic androgenic steroid dependence: a case report in the context of current best clinical practice">
<meta name="citation_author" content="Raphael Magnolini">
<meta name="citation_author_institution" content="Arud Centre for Addiction Medicine, Schuetzengasse 31, 8001 Zurich, Switzerland">
<meta name="citation_author_institution" content="Institute of Primary Care, University Hospital Zurich, University of Zurich, Zurich, Switzerland">
<meta name="citation_author" content="Sofia Laura Bottoni">
<meta name="citation_author_institution" content="Institute of Primary Care, University Hospital Zurich, University of Zurich, Zurich, Switzerland">
<meta name="citation_author_institution" content="Faculty of Medicine, University of Zurich, Zurich, Switzerland">
<meta name="citation_author" content="Helena Hammer">
<meta name="citation_author_institution" content="HerzGefaessZentrum im Park, Hirslanden Group, Zurich, Switzerland">
<meta name="citation_author_institution" content="Herzpraxis Stadelhofen, Zurich, Switzerland">
<meta name="citation_author" content="Joël Capraro">
<meta name="citation_author_institution" content="Department of Endocrinology, Diabetology and Metabolism, Cantonal Hospital Aarau, Aarau, Switzerland">
<meta name="citation_author" content="Philip Bruggmann">
<meta name="citation_author_institution" content="Arud Centre for Addiction Medicine, Schuetzengasse 31, 8001 Zurich, Switzerland">
<meta name="citation_author_institution" content="Institute of Primary Care, University Hospital Zurich, University of Zurich, Zurich, Switzerland">
<meta name="citation_author" content="Oliver Senn">
<meta name="citation_author_institution" content="Institute of Primary Care, University Hospital Zurich, University of Zurich, Zurich, Switzerland">
<meta name="citation_publication_date" content="2025 Aug 21">
<meta name="citation_volume" content="22">
<meta name="citation_firstpage" content="144">
<meta name="citation_doi" content="10.1186/s12954-025-01294-w">
<meta name="citation_pmid" content="40841640">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369084/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369084/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369084/pdf/12954_2025_Article_1294.pdf">
<meta name="description" content="The non-medical use of androgens among recreational gym users has become a global substance use concern. Complications from use particularly appear to affect the cardiovascular system, including the development of cardiovascular events, as well as ...">
<meta name="og:title" content="Harm reduction measures in a recreational gym user with anabolic androgenic steroid dependence: a case report in the context of current best clinical practice">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="The non-medical use of androgens among recreational gym users has become a global substance use concern. Complications from use particularly appear to affect the cardiovascular system, including the development of cardiovascular events, as well as ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369084/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12369084">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s12954-025-01294-w"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/12954_2025_Article_1294.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12369084%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12369084/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12369084/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369084/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-harmred.png" alt="Harm Reduction Journal logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Harm Reduction Journal" title="Link to Harm Reduction Journal" shape="default" href="https://harmreductionjournal.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Harm Reduct J</button></div>. 2025 Aug 21;22:144. doi: <a href="https://doi.org/10.1186/s12954-025-01294-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s12954-025-01294-w</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Harm%20Reduct%20J%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Harm%20Reduct%20J%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Harm%20Reduct%20J%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Harm%20Reduct%20J%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Harm reduction measures in a recreational gym user with anabolic androgenic steroid dependence: a case report in the context of current best clinical practice</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Magnolini%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Raphael Magnolini</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Raphael Magnolini</span></h3>
<div class="p">
<sup>1</sup>Arud Centre for Addiction Medicine, Schuetzengasse 31, 8001 Zurich, Switzerland </div>
<div class="p">
<sup>2</sup>Institute of Primary Care, University Hospital Zurich, University of Zurich, Zurich, Switzerland </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Magnolini%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Raphael Magnolini</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bottoni%20SL%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Sofia Laura Bottoni</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Sofia Laura Bottoni</span></h3>
<div class="p">
<sup>2</sup>Institute of Primary Care, University Hospital Zurich, University of Zurich, Zurich, Switzerland </div>
<div class="p">
<sup>3</sup>Faculty of Medicine, University of Zurich, Zurich, Switzerland </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bottoni%20SL%22%5BAuthor%5D" class="usa-link"><span class="name western">Sofia Laura Bottoni</span></a>
</div>
</div>
<sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hammer%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Helena Hammer</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Helena Hammer</span></h3>
<div class="p">
<sup>4</sup>HerzGefaessZentrum im Park, Hirslanden Group, Zurich, Switzerland </div>
<div class="p">
<sup>5</sup>Herzpraxis Stadelhofen, Zurich, Switzerland </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hammer%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Helena Hammer</span></a>
</div>
</div>
<sup>4,</sup><sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Capraro%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Joël Capraro</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Joël Capraro</span></h3>
<div class="p">
<sup>6</sup>Department of Endocrinology, Diabetology and Metabolism, Cantonal Hospital Aarau, Aarau, Switzerland </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Capraro%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Joël Capraro</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bruggmann%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Philip Bruggmann</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Philip Bruggmann</span></h3>
<div class="p">
<sup>1</sup>Arud Centre for Addiction Medicine, Schuetzengasse 31, 8001 Zurich, Switzerland </div>
<div class="p">
<sup>2</sup>Institute of Primary Care, University Hospital Zurich, University of Zurich, Zurich, Switzerland </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bruggmann%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Philip Bruggmann</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Senn%20O%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Oliver Senn</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Oliver Senn</span></h3>
<div class="p">
<sup>2</sup>Institute of Primary Care, University Hospital Zurich, University of Zurich, Zurich, Switzerland </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Senn%20O%22%5BAuthor%5D" class="usa-link"><span class="name western">Oliver Senn</span></a>
</div>
</div>
<sup>2</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Arud Centre for Addiction Medicine, Schuetzengasse 31, 8001 Zurich, Switzerland </div>
<div id="Aff2">
<sup>2</sup>Institute of Primary Care, University Hospital Zurich, University of Zurich, Zurich, Switzerland </div>
<div id="Aff3">
<sup>3</sup>Faculty of Medicine, University of Zurich, Zurich, Switzerland </div>
<div id="Aff4">
<sup>4</sup>HerzGefaessZentrum im Park, Hirslanden Group, Zurich, Switzerland </div>
<div id="Aff5">
<sup>5</sup>Herzpraxis Stadelhofen, Zurich, Switzerland </div>
<div id="Aff6">
<sup>6</sup>Department of Endocrinology, Diabetology and Metabolism, Cantonal Hospital Aarau, Aarau, Switzerland </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Mar 9; Accepted 2025 Aug 1; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12369084  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40841640/" class="usa-link">40841640</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Introduction</h3>
<p id="Par1">The non-medical use of androgens among recreational gym users has become a global substance use concern. Complications from use particularly appear to affect the cardiovascular system, including the development of cardiovascular events, as well as anabolic steroid-induced cardiomyopathy (ASIC). Furthermore, the development of substance dependence with a specific withdrawal syndrome appears to be common and is contributed by the development of endocrine dysfunction related to anabolic steroid-induced hypogonadism.</p></section><section id="sec2"><h3 class="pmc_sec_title">Case summary</h3>
<p id="Par2">A 38-year-old male law enforcement officer and recreational bodybuilder presented with multiple health complaints following years of supraphysiologic androgen use and polypharmacy. Key symptoms included new-onset subacute dyspnea, dizziness, palpitations, headaches, and recurrent failed attempts at androgen cessation. Clinical findings showed abnormal blood pressure, testicular atrophy, plethoric appearance, and laboratory evidence of progressive polycythemia (hematocrit: 56.9%; normal &lt; 49%), elevated testosterone, and suppressed luteinizing and follicle-stimulating hormones. He was at risk for muscle dysmorphia and met criteria for androgen dependence. Diagnosis confirmed ASIC. Treatment consisted of recurrent bloodletting for polycythemia, guideline-based cardiac management, and a structured endocrine regimen (tapered transdermal testosterone, oral Tamoxifen, subcutaneous human chorionic gonadotropin) to support androgen discontinuation and hormonal recovery. At 4 months, ASIC had normalized, and he was asymptomatic. However, after 6 months, he developed laboratory-confirmed idiopathic primary hypogonadism and began guideline-directed testosterone replacement. Despite more than a year of abstinence from non-medical androgen use and normalization of cardiac function, the patient died from a cardiovascular event, highlighting the possibly persistent risks of prior androgen use.</p></section><section id="sec3"><h3 class="pmc_sec_title">Conclusion</h3>
<p id="Par3">Non-medical androgen use is a growing global issue among recreational gym-goers. The intersection of severe health risks and substance dependence highlights the urgent need for an integrated, medical and harm-reduction approach—ideally delivered in specialized primary care settings. Early detection of cardiovascular risk factors is crucial for mitigating the often-overlooked yet potentially reversible complications. A reassessment of legal and clinical measures is warranted to optimize harm reduction and provision of care. Despite best practices and a year of abstinence from non-medical androgen use, the patient’s fatal outcome underscores the critical need for further research, heightened awareness, and more robust prevention and harm reduction strategies for those affected by non-medical androgen use.</p></section><section id="sec4"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1186/s12954-025-01294-w.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Anabolic androgenic steroids, Substance use disorder, Hypogonadism, Cardiomyopathy, Addiction, Polycythemia, Case report</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par18">Anabolic androgenic steroid use, which includes natural androgens, e.g., testosterone, or could be synthetic derivatives to mimic the action of the endogenous male sex hormones, has become a major global health concern, particularly among young males who engage in recreational sports with the motivation of improving personal aesthetic goals [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>–<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. The non-medical use of androgens most often comprises of complex supraphysiologic user patterns over months and/or chronic use over years with additional extensive polypharmacy with other medications and possible concomitant illicit substance use [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>, <a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. Acute and long-term side effects from androgen use are multiple, complex, and potentially detrimental regarding health outcomes among people using these substances [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>, <a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>–<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. Among the many complications from androgen use, particularly the cardiovascular system appears to be affected with the development of cardiovascular disease (i.e., acute myocardial infarction, venous thromboembolism, arrhythmias, heart failure [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]), as well as anabolic steroid-induced cardiomyopathy (ASIC) which has become a growing health concern [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>, <a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>–<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>].</p>
<p id="Par19">Furthermore, the development of substance dependence is common among people who are using androgens that fulfills the adapted criteria of a substance use disorder (SUD) [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>, <a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>, <a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>] and most often is contributed by the development of endocrine dysfunction related to an anabolic steroid-induced hypogonadism (ASIH) [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>, <a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>, <a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. Approximately one-third of those who start using androgens appear to develop a dependence syndrome [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. The development of substance dependence among people who use androgens can contribute to continued use of these substances, even though negative health complications are already present, and unsuccessful attempts at androgen cessation appear to be common as well in that context [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>].</p>
<p id="Par20">This current case report presents a patient who engaged in recreational sports using androgens and was diagnosed with ASIC and screened for anabolic steroid dependence presenting in a primary care setting specialized for anabolic steroid use in Switzerland. This report highlights not only the successful reversibility of ASIC with comprehensive harm-reduction measures in an integrated primary care setting but also the sobering reality that, despite such dedicated multidisciplinary care and prolonged abstinence from non-medical androgen use, the patient ultimately suffered a fatal cardiovascular event. This outcome underscores the persistent and potentially irreversible risks associated with prior long-term androgen use, even in the context of best-practice medical management.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Methods</h2>
<p id="Par21">A primary healthcare practice for current or past users of androgens in recreational sports was established at the Arud Centre for Addiction Medicine in Zurich (Switzerland) to improve the provision of medical care for people who are using anabolic agents from 2023 onwards [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. The Arud Centre provides integrated medical care for patients with problematic substance use or substance use disorders. This case report’s reporting and methodology follow a checklist for case reports using the CARE guidelines [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. The complete reporting checklist is available in Supplementary Table <a href="#MOESM1" class="usa-link">1</a>.</p>
<section id="Sec3"><h3 class="pmc_sec_title">Patient information/medical history</h3>
<p id="Par22">A 38-year-old law enforcement professional and recreational bodybuilder presented for laboratory monitoring and guidance during ongoing androgen use. Although motivated to stop, he was ambivalent about maintaining long-term abstinence. At his first visit, he reported new-onset subacute dyspnea and dizziness during strenuous exercise, as well as recurrent palpitations, headaches, excessive sweating, and reduced testicular volume. He also experienced sleep disturbances suggestive of obstructive sleep apnea and progressive male pattern hair loss. No initial mental health concerns were noted. The patient reported weekly supraphysiologic testosterone injections, prior oral use, and concurrent use of anabolic agents. He reported weekly use of testosterone propionate 300 mg/week, nandrolone phenylpropionate 300 mg/week, insulin 10 IU/day, and growth hormone (hGH) 6 IU/day. He reported not to take other medications and had no significant personal or family history of cardiovascular disease, cancer, or risk factors. He was a lifelong non-smoker, consumed minimal alcohol, and denied illicit drug use. Previous attempts to discontinue androgens, unaccompanied by medical supervision and relying on anecdotal “post-cycle therapy” to support withdrawal from non-medical androgen use [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>, <a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>]—resulted in withdrawal symptoms (i.e., depressed mood, anxiety, insomnia, low energy, decreased libido) leading to repeated relapse. These symptoms align with anabolic steroid-induced hypogonadism (ASIH) following prolonged androgen exposure.</p></section><section id="Sec4"><h3 class="pmc_sec_title">Clinical findings/physical examination</h3>
<p id="Par23">On examination, the patient appeared well and not in distress. Blood pressure was elevated (160/81 mmHg), and BMI was high at 33.9 kg/m2 with pronounced muscle bulk. Cardiovascular exam was normal, with no fluid overload or abnormal heart sounds. He was noted to be plethoric (florid; red-faced). Notable findings included underarm stretch marks, advanced male pattern hair loss (Hamilton-Norwood stage V), and testicular atrophy (&lt; 15 mL by self-assessment by Orchidometry). No lymphadenopathy, thyroid enlargement, or other abnormalities were detected by physical examination.</p></section><section id="Sec5"><h3 class="pmc_sec_title">Timeline</h3>
<p id="Par24">See Table <a href="#Tab1" class="usa-link">1</a>.</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Timeline of historical and clinical information</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Timeline</th>
<th align="left" colspan="1" rowspan="1">Historical and clinical information</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">− 12 to 15 years</td>
<td align="left" colspan="1" rowspan="1">First time exogenous anabolic androgenic steroid use with cyclic application over a total of 8 years</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">Presentation at the primary care practice with a focused assessment of patient history, as well as physical, laboratory (blood and urine), psychometric (androgen dependence, muscle dysmorphia), instrumental (ECG) examination</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">+ 1 week</td>
<td align="left" colspan="1" rowspan="1">Referral to outpatient cardiology clinic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">+ 3 weeks</td>
<td align="left" colspan="1" rowspan="1">Follow-up visit demonstrated progressive symptomatic polycythemia with splenomegaly treated with recurrent phlebotomy procedures</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">+ 4 weeks</td>
<td align="left" colspan="1" rowspan="1">Diagnosis of cardiomyopathy and hypertension</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">+ 1 month</td>
<td align="left" colspan="1" rowspan="1">Attempt of cessation of anabolic androgenic steroids supported with an endocrine tapering treatment protocol</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">+ 4 months</td>
<td align="left" colspan="1" rowspan="1">
<p>Follow-up cardiology examination showing normalization of ventricular structure and function and blood pressure</p>
<p>Follow-up laboratory examination showing normalization of polycythemia</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">+ 6 months</td>
<td align="left" colspan="1" rowspan="1">
<p>Follow-up laboratory, clinical and ultrasound exam, as well as stimulation test showing sustained symptomatic endocrine dysfunction and state of hypogonadism</p>
<p>Commencement of medical testosterone replacement therapy (TRT)</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">+ 7 months</td>
<td align="left" colspan="1" rowspan="1">Persisting risk for androgen dependence and body dysmorphia</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">+ 11 months</td>
<td align="left" colspan="1" rowspan="1">Positive OSA screening with referral to outpatient pneumology department. Diagnosis of OSA was refuted</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">+ 16 months</td>
<td align="left" colspan="1" rowspan="1">
<p>Abdominal sonography showing persisting splenomegaly</p>
<p>Patient remained abstinent (self-reported and further objectified by laboratory markers) with continued wish for abstinence from non-medical use of anabolic androgenic steroids under medical testosterone replacement therapy</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">+ 19 months</td>
<td align="left" colspan="1" rowspan="1">The patient died from a cardiovascular event. After death, it was discovered that he had an unreported HIV diagnosis</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec6"><h3 class="pmc_sec_title">Diagnostic assessment/measures</h3>
<p id="Par25">Further diagnostic work included laboratory (blood and urine) and ECG examinations. Table <a href="#Tab2" class="usa-link">2</a> presents key lab findings; all results are available in the supplementary Table <a href="#MOESM1" class="usa-link">2</a>. Abnormal results included polycythemia, mildly elevated liver enzymes, suppressed LH/FSH (indicating hypothalamic-pituitary axis suppression), elevated androgens and estrogens, and dyslipidemia characterized by low HDL. Creatine kinase was moderately elevated. Kidney function tests showed normal eGFR but albuminuria (category A2), suggesting possible kidney pathology. Other labs were unremarkable. A 12-lead ECG indicated left ventricular hypertrophy (Sokolov-Lyon index: 3.5 mV) as demonstrated in Fig. <a href="#Fig1" class="usa-link">1</a>A. Psychometric screening identified risk for muscle dysmorphia (Muscle Dysmorphic Disorder Inventory (MDDI): 47; norm &lt; 39) and androgen dependence (adapted DSM-V: 5/7 criteria; norm &lt; 3) [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>, <a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]. The patient declined further psychiatric or psychotherapeutic evaluation.</p>
<section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Summary table of key clinical measurements</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" rowspan="2" colspan="1">Investigation</th>
<th align="left" colspan="7" rowspan="1">Date</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">24.08.23</th>
<th align="left" colspan="1" rowspan="1">11.09.23</th>
<th align="left" colspan="1" rowspan="1">30.10.23</th>
<th align="left" colspan="1" rowspan="1">29.01.24</th>
<th align="left" colspan="1" rowspan="1">04.03.24</th>
<th align="left" colspan="1" rowspan="1">26.03.24</th>
<th align="left" colspan="1" rowspan="1">16.05.24</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Blood pressure (mmHg)</td>
<td align="left" colspan="1" rowspan="1">160/81</td>
<td align="left" colspan="1" rowspan="1">149/71</td>
<td align="left" colspan="1" rowspan="1">133/67</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">147/78</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">24h blood pressure (mmHg)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">154/77***</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">116/65****</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr><td align="left" colspan="8" rowspan="1"><em>Hematology</em></td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">RCC (10e6/uL) (4.6–6.2)</td>
<td align="left" colspan="1" rowspan="1">5.81</td>
<td align="left" colspan="1" rowspan="1">6.25</td>
<td align="left" colspan="1" rowspan="1">5.46</td>
<td align="left" colspan="1" rowspan="1">4.88</td>
<td align="left" colspan="1" rowspan="1">4.86</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">5.32</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Hemoglobin (Hb) (g/dL) (14–18) </td>
<td align="left" colspan="1" rowspan="1">17.9</td>
<td align="left" colspan="1" rowspan="1">19</td>
<td align="left" colspan="1" rowspan="1">17.4</td>
<td align="left" colspan="1" rowspan="1">15.4</td>
<td align="left" colspan="1" rowspan="1">15.5</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">17</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Hematocrit (HCT) (%) (43–49) </td>
<td align="left" colspan="1" rowspan="1">52.8</td>
<td align="left" colspan="1" rowspan="1">56.9</td>
<td align="left" colspan="1" rowspan="1">50</td>
<td align="left" colspan="1" rowspan="1">43.1</td>
<td align="left" colspan="1" rowspan="1">44.4</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">48.1</td>
</tr>
<tr><td align="left" colspan="8" rowspan="1"><em>Chemistry</em></td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">FSH (IU/l) (1.5–12.4)</td>
<td align="left" colspan="1" rowspan="1">0.3</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">&lt; 0.3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">LH (IU/L) (1.7–8.6)</td>
<td align="left" colspan="1" rowspan="1">0.3</td>
<td align="left" colspan="1" rowspan="1">&lt; 0.3</td>
<td align="left" colspan="1" rowspan="1">0.3</td>
<td align="left" colspan="1" rowspan="1">9.4</td>
<td align="left" colspan="1" rowspan="1">9.2</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">&lt; 0.3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Total Testosterone (tT) (nmol/l) (8.6–29.0)</td>
<td align="left" colspan="1" rowspan="1">43.6</td>
<td align="left" colspan="1" rowspan="1">8.3</td>
<td align="left" colspan="1" rowspan="1">44.5</td>
<td align="left" colspan="1" rowspan="1">6.5</td>
<td align="left" colspan="1" rowspan="1">8.2</td>
<td align="left" colspan="1" rowspan="1">7.7</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Free Testosterone* (fT) (pmol/l) (16.7–77.8)</td>
<td align="left" colspan="1" rowspan="1">166.2</td>
<td align="left" colspan="1" rowspan="1">27.4</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Free Testosterone** (fT) (pmol/l) (198–619)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">1140</td>
<td align="left" colspan="1" rowspan="1">108</td>
<td align="left" colspan="1" rowspan="1">108</td>
<td align="left" colspan="1" rowspan="1">112</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Estradiol (pmol/l) (41.4–159)</td>
<td align="left" colspan="1" rowspan="1">258</td>
<td align="left" colspan="1" rowspan="1">29</td>
<td align="left" colspan="1" rowspan="1">176</td>
<td align="left" colspan="1" rowspan="1">55</td>
<td align="left" colspan="1" rowspan="1">23</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p21">
<p>*Determination of bioactive testosterone by direct measurement</p>
<p>**Determination of free testosterone by calculation with formula of Vermeulen</p>
<p>***24 h blood pressure measurement conducted 21.09.2023</p>
<p>****24 h blood pressure measurement conducted 08.01.2024</p>
</div></div></section><figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369084_12954_2025_1294_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ffe/12369084/b0ce9be1a934/12954_2025_1294_Fig1_HTML.jpg" loading="lazy" id="MO1" height="572" width="669" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Results from 12-lead electrocardiogram and cardiac ultrasound on initial presentation and follow-up after androgen cessation and antihypertensive treatment. After 8 years of cyclic androgen use, the resting ECG demonstrated signs of left ventricular hypertrophy (LVH) (<strong>A</strong>), 4 months after stopping non-medical androgen use and antihypertensive treatment, no signs of LVH could be documented by ECG (<strong>B</strong>). Echocardiographic confirmation of LVH (concentric hypertrophic left ventricle with maximum septal thickness of 14 mm), normal pump function (LVEF 65%), but reduced longitudinal function (GLS -15%) as demonstrated in the parasternal longitudinal axis view (<strong>C</strong>) and 4-chamber view (<strong>E</strong>). Pleasant cardiological course 4 months after also by echocardiographic assessment with normalization of structural changes (max. septum thickness 10-11 mm, normal pump function, normalization of longitudinal deformation (GLS -17.5%) as demonstrated in the parasternal longitudinal axis view (<strong>D</strong>) and 4-chamber view (<strong>F</strong>)</p></figcaption></figure><p id="Par26">For further cardiac assessment, the patient was referred to an outpatient cardiology clinic. Transthoracic echocardiography (TTE) confirmed concentric hypertrophy (septal thickness: 14 mm) with normal ejection fraction (LVEF: 65%) but reduced longitudinal strain (GLS -15%) as demonstrated in Fig. <a href="#Fig1" class="usa-link">1</a>C, E. Mild mitral valve insufficiency was noted. Diagnosis was consistent with ASIC. A 24-h blood pressure test confirmed grade 1 hypertension (mean: 154/77 mmHg) and a hypertrophic component of cardiomyopathy would be a differential diagnosis. HFpEF was considered, but assessment was limited by tachycardia and lack of cardiac biomarkers. Exercise-induced cardiomegaly (‘athlete’s heart’) was ruled out due to reduced GLS, no cavity dilatation, and absence of other adaptations.</p>
<p id="Par27">Nocturnal breathing difficulties prompted screening for obstructive sleep apnea (OSA); pulse oximetry indicated mild OSA (AHI: 7.0), but sleep laboratory studies later refuted this. Abdominal ultrasound showed splenomegaly (17 × 6 cm) with no other abdominal abnormalities. Testicular ultrasound revealed atrophy (12–13 cm<sup>3</sup>), minor hydrocele, and a small spermatocele (10 mm), but normal structure and perfusion. No semen analysis was performed as there was no desire for future fertility.</p></section><section id="Sec7"><h3 class="pmc_sec_title">Therapeutic intervention</h3>
<section id="Sec8"><h4 class="pmc_sec_title">Cardiovascular and hematologic risks</h4>
<p id="Par28">Primary treatment recommendations for anabolic steroid-induced hypertension and cardiomyopathy included androgen and growth hormone cessation. Furthermore, the patient received guideline-directed antihypertensive therapy for stage 1 arterial hypertension, consisting of low-dose monotherapy with Lisinopril 5 mg daily (an ACE inhibitor) to also promote left ventricular cardiac remodeling, as per European Society of Cardiology (ESC) guidelines [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]. It is important to note that the introduction of ACE inhibitor therapy coincided with the cessation of androgens and growth hormones, which may complicate the interpretation of subsequent cardiovascular improvements. This overlap raises questions about the precise contribution of each intervention to the observed reversal of cardiovascular risk and the potential for recovery from ASIC. In a patient with established LVH (high risk), a dual antihypertensive therapy could be discussed if the systole is &gt; 150 mmHg and androgen cessation could not be achieved. Due to a lack of evidence to establish the diagnosis of HFpEF, no treatment with an additional SGLT2 inhibitor was initiated. Other cardiovascular harm-reducing treatments included two phlebotomy treatments, also referred to as bloodletting treatments, due to progression of a severe symptomatic polycythemia (i.e., hematocrit level 56.9% (high hematocrit: &gt; 54%) with two sessions of approximately 500 mL blood withdrawals each session. It should be noted that one bloodletting (phlebotomy) procedure was performed in the primary care setting. In contrast, an additional phlebotomy was independently conducted by the patient with the assistance of peers. This latter procedure took place within 4 weeks following the first session and occurred without the prior knowledge or supervision of the treating physician.</p></section><section id="Sec9"><h4 class="pmc_sec_title">Anabolic steroid-induced hypogonadism</h4>
<p id="Par29">Regarding endocrine treatment of hyperestrogenism, he was initially started on Letrozole 2.5 mg daily (aromatase inhibitor; AI) to reduce aromatization of testosterone to estradiol until androgen cessation was attempted. Thereafter, regarding cessation, there was a high risk of development of ASIH with associated withdrawal symptoms due to endocrine dysfunction of his HPT axis, as previously reported by the patient in the past. A tapering protocol according to Rahnema and colleagues was applied aiming to reduce withdrawal symptoms and to restore endogenous testosterone synthesis [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. Treatment included a 4-week tapering of transdermal testosterone gel (60 mg to 20 mg/day), a 10-week course of Tamoxifen 20 mg daily (then reduced to 10 mg for 6 weeks) to stimulate endogenous gonadotropin release, and a 4-week rescue regimen of hCG (2000 IE, 3 times weekly). The patient was monitored over 6 months.</p></section></section><section id="Sec10"><h3 class="pmc_sec_title">Follow-up and outcomes</h3>
<section id="Sec11"><h4 class="pmc_sec_title">Cardiovascular and hematologic risks</h4>
<p id="Par30">After 4 months of the guideline-directed medical therapy for arterial hypertension as well as androgen and growth hormone cessation and associated weight loss, the patient recovered clinically with normalized cardiac function and structure demonstrated in repeat ECG as well as echocardiogram (Fig. <a href="#Fig1" class="usa-link">1</a>B, D, F) with resolution of the left ventricular hypertrophy (maximum septal thickness: 10-11 mm) and normal longitudinal function (GLS -17.5%). Cardiac biomarker (i.e., NT-proBNP) was normal. Importantly, upon the patient’s cardiovascular assessment and diagnosis of anabolic steroid-induced cardiomyopathy, an abstinence motivation could be further promoted and the patient wanted to quit androgen use permanently. The arterial hypertension normalized under antihypertensive treatment and weight loss confirmed by a 24-h home blood pressure measurement (mean pressure: 116/65 mmHg). Upon androgen cessation and medical antihypertensive treatment the patient reported multiple orthostatic hypotensive episodes, and antihypertensive treatment was stopped with no further episodes reported. Initial phlebotomy treatment led to cardiovascular symptom improvement (i.e., headaches, dizziness, plethora) and reduction of hematocrit (50%). In combination with cessation the patient’s hematocrit normalized. Splenomegaly remained stable (16.6 × 6 cm) at 16 months past cessation. Furthermore, dyslipidemia resolved without medical treatment, and Albuminuria improved.</p></section><section id="Sec12"><h4 class="pmc_sec_title">Anabolic steroid-induced hypogonadism</h4>
<p id="Par31">Over 4 months of endocrine therapy, the patient's withdrawal symptoms were initially controlled. A notable peak in total testosterone (44.5 nmol/L; 30 October 2023) likely resulted from the combined use of hCG and tapering testosterone. The patient followed the protocol, experiencing only minor skin irritation from the testosterone gel, which resolved with site rotation. No other adverse events were reported. Within 6 months, symptoms of hypogonadism worsened, as evidenced by The Aging Males' Symptoms (AMS) score (43; normal ≤ 26) [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>], low testosterone (tT: 8.2 nmol/L; fT: 108 pmol/L), and elevated LH (9.2 IU/L). Physiological testosterone levels could not be restored, as shown in Fig. <a href="#Fig2" class="usa-link">2</a>. A guideline-directed hCG stimulation test was conducted. Even a high dose stimulation test (5000 IE hCG as single injection) did not show a sufficient testosterone increase (tT: 1.2x; fT: 1.3x (normal: 1.8–2.5x)), reflecting gonadal failure (primary hypogonadism). In this case, the diagnosis is best classified as idiopathic primary hypogonadism. While androgen use may have been a substantial factor, other factors such as prior cryptorchidism, orchitis, genetic conditions like Klinefelter syndrome, or longstanding HIV infection and its treatment may have contributed. However, these cannot be definitively assessed anymore. This underscores both the multifactorial nature of hypogonadism and the limitations of retrospective analysis in complex cases. There is currently no consensus on the optimal duration of this endocrine treatment; thus, the patient may have benefited from a longer treatment period to facilitate endocrine recovery. As there was a high chance of relapse to non-medical use of anabolic steroid due to progressively worsening symptoms as indicated by the patient as well as the possibly of irreversible state of hypogonadism, the patient was started on standard of care testosterone replacement therapy (TRT), which led to complete resolution of symptoms associated with low testosterone (i.e., AMS: 22 points; normal: &lt; 26 points) [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. The patient reported that he remained abstinent from non-medical androgen use until the last known consultation (&gt; 16 months after cessation). Signs for body dysmorphic disorder (i.e., muscle dysmorphia) assessed MDDI (i.e., 44 points; normal: &lt; 39 points) persisted upon cessation, but no further psychiatric evaluation or treatment was wanted by the patient.</p>
<figure class="fig xbox font-sm" id="Fig2"><h5 class="obj_head">Fig. 2.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369084_12954_2025_1294_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ffe/12369084/0bd6ae3bc8b3/12954_2025_1294_Fig2_HTML.jpg" loading="lazy" id="MO2" height="342" width="669" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Course of testosterone recovery after androgen cessation. Course of testosterone recovery after cessation of non-medical androgen use. The patient received endocrine treatment for 4 months according to a tapering protocol by Rahnema and colleagues [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. His endogenous testosterone did not recover over an observation period of 6 months, and he developed progressive symptoms consistent with ASIH</p></figcaption></figure></section></section><section id="Sec13"><h3 class="pmc_sec_title">Postmortem insights and clinical reflections</h3>
<p id="Par32">During the manuscript review process, it was reported that the patient passed away. Although an official autopsy report is not available, based on correspondence with the hospital, the most probable cause of death was attributed to a cardiovascular event (i.e., lung embolism). A post-mortem assessment revealed that the patient had been living with HIV, a diagnosis unknown and not disclosed during the initial case study. The patient was diagnosed with HIV (CDC Stage A1) in 2012. The patient’s antiretroviral treatment (ART) history includes the use of rilpivirin (25 mg), tenofovir alafenamide (25 mg) and emtricitabine (200 mg) at the time of death. Throughout the course of treatment, the patient has maintained sustained viral suppression. An external consult with a clinical pharmacology specialist was conducted, who identified a theoretical but unproven interaction between emtricitabine and testosterone therapy. Both drugs are partially eliminated by the kidneys, which could cause competition at renal transporters and affect clearance. Changes in testosterone metabolite excretion might also raise systemic androgen levels through increased recycling. Notably, this remains a theoretical consideration, as there is currently no clinical evidence to support a significant interaction and was not evident in this patient under TRT treatment.</p>
<p id="Par33">Importantly, while TRT is often necessary for treating hypogonadism, emerging evidence from randomized controlled trials (TRAVERSE trial) has demonstrated that TRT alone can confer an individual risk for serious cardiovascular events, most notably pulmonary embolism and atrial fibrillation [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]. This risk highlights the importance for careful patient selection and monitoring during TRT. This unexpected discovery highlights the complexity of comorbid conditions. It reinforces the importance of comprehensive medical assessments, particularly in cases involving multiple health challenges such as long-term substance use of androgens, which can lead to significant cardiovascular risks [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. Studies have shown that non-medical androgen use may increase the likelihood of developing complications such as myocardial injury, hypertrophic cardiomyopathy, arrhythmias, and vascular damage, all of which contribute to heightened cardiovascular morbidity and mortality [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. Additionally, HIV itself is a recognized cardiovascular risk factor as well as risk factor for acquiring hypogonadism, further emphasizing the need for integrated care [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>, <a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. It is also essential to highlight that many individuals in this community frequently use fitness supplements and high-dose vitamin products procured from unregulated underground laboratories, as also possible in this case [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>, <a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. These items are often counterfeit or do not contain the advertised ingredients and may harbor potentially harmful or undisclosed substances [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>, <a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. The unchecked consumption of such supplements, absent proper oversight, can result in serious health complications—especially for those already at risk due to excessive androgen use.</p></section></section><section id="Sec14"><h2 class="pmc_sec_title">Discussion</h2>
<section id="Sec15"><h3 class="pmc_sec_title">Epidemiology and androgen dependence</h3>
<p id="Par34">In this case report, we described a 38-year-old male recreational bodybuilder who developed ASIC and was screened for androgen dependence in a Swiss primary care setting specializing in non-medical androgen use. Tragically, during the manuscript review process, the patient passed away, with the most probable cause of death attributed to a cardiovascular event.</p>
<p id="Par35">Globally, the lifetime prevalence of androgen use is estimated at 6.4% among males and 18.4% among recreational gym users [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]. For Switzerland, this translates to an estimated 300,000 people having used AAS at least once, though precise national data are lacking [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>, <a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>]. Notably, about one-third (34.4%) of those who begin AAS use develop dependence or chronic use [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. The development of a substance dependence among people that use androgens can contribute to continued use of these substances contributed by the development of body-image concerns (anabolic effects), endocrine dysfunction (androgenic effects), as well as mechanisms shared with classical addictive drugs (hedonic effects) [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>, <a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>]. The long-term treatment should include integrated (addiction-) medical and psychiatric care approaches as it appears that unsuccessful cessation attempts are frequent among this population [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. Long-term androgen users are at risk of both psychological and physical dependence, with withdrawal symptoms such as mood changes, aggression, and fatigue. It is crucial to distinguish addiction—characterized by cravings and compulsive use—from physical dependence, which primarily involves withdrawal symptoms, to ensure appropriate treatment [<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>, <a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. The rise of anabolic steroid-use disorder is concerning, yet research into its mechanisms and optimal management remains limited. More studies are needed to improve and validate diagnostic criteria and develop effective treatments that support hypothalamic-pituitary axis recovery while addressing the broader neurobiological and hormonal effects of androgen use.</p>
<p id="Par36">Given the high prevalence and growing popularity of androgens, healthcare providers must be knowledgeable about the individual and public health risks associated with these substances. Many individuals self-medicate and seek advice from peers or online forums, turning to specialized or emergency care only for severe side effects [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]. Hospitalization rates for androgen users are significantly higher than for non-users [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]. Barriers to accessing regular healthcare include fear of stigma or judgment, lack of trust in healthcare professionals, concerns about legal repercussions, and difficulty obtaining necessary medications for androgen-related complications [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>].</p></section><section id="Sec16"><h3 class="pmc_sec_title">Cardiovascular and hematologic risks</h3>
<p id="Par37">This patient received integrated care focused on minimizing cardiovascular and hematologic risks from long-term androgen use. Routine monitoring included regular assessments of cardiac function and blood parameters. Despite cessation of androgen use and harm reduction measures, the patient ultimately died due to a cardiovascular event—most likely a pulmonary embolism. This outcome underscores the persistent and possibly substantial risks faced by individuals with a prolonged history of androgen use and coexisting medical conditions. Among the known health risks of non-medical androgen use, cardiovascular complications appear to be particularly substantial [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>, <a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>–<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. While large trials found TRT in hypogonadal men was not inferior to placebo regarding major cardiac events although use may carry an elevated risk for pulmonary embolism, the impact of non-medical, supraphysiologic use remains unclear and may depend on dose and compounds used [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>, <a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. Case–control studies indicate androgen users have a higher mortality risk, especially from cardiovascular causes, though high-quality data are limited [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>, <a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>, <a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>, <a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>, <a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>].</p>
<p id="Par38">The non-medical use of AAS may result in a series of complications on the cardiovascular system including vascular injury as well as anabolic steroid-induced cardiomyopathy with/without heart failure from myocardial injury (i.e., atherogenic and prothrombotic effects, and vasoconstriction) as well as biventricular dysfunction (i.e., hypertrophic changes, increased blood pressure, and cardiac remodeling) which may culminate in those patients alongside more risk factors such as arrhythmias, obstructive sleep apnea, or polycythemia [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>, <a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>, <a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>–<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>]. The underlying pathobiology based on the current understanding is summarized in the supplementary Table <a href="#MOESM1" class="usa-link">4</a>. Cardiovascular risks as well as risk for cardiomyopathy can accumulate in this population with the concomitant use of image- and performance-enhancing drugs, such as growth hormones in this patient [<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>]. This underlines that cardiovascular case findings may be frequent among patients using androgens and screening recommendations regarding cardiovascular risk factors should be conducted among this population. The risk of people using androgens suffering from acute myocardial infarction at a young age may be 3% [<a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>]. The development of ASIC may be a frequent, yet an underrecognized and underreported outcome [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>, <a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. The reversibility of ASIC varies and may depend on different factors (i.e., type, strength, duration of androgen use, polypharmacy with other anabolic agents, and concomitant illicit substance use) and is conversely discussed within the medical literature [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. Timely diagnosis as well as adequate early treatment initiation may be crucial to avoid disease progression and irreversible damage from a complication that most often goes unnoticed in early stages. Findings in ECG exams are common among sportspeople as well as people using androgens. The differentiation of normal (e.g., athletes’ heart) and abnormal (e.g., LVH) ECG findings can be challenging, although different ECG indices could be applied (e.g., Sokolow-Lyon index, modified Sokolow-Lyon index, Cornell voltage QRS duration product, Romhilt-Estes score, Seattle Criteria) [<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>–<a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>]. Given the prevalence of ECG abnormalities among athletes and androgen users, we recommend discussing findings with a cardiology specialist and considering prompt low-threshold referral for additional diagnostics, such as echocardiography. Notably, a timely referral and the visualization of cardiomyopathy via echocardiography prompted this patient to reconsider substance use and helped foster ongoing abstinence. This intervention may have contributed to the complete reversibility observed.</p>
<p id="Par39">Notably, the patient exhibited significant muscle mass objectified by BMI assessment. While more detailed assessments of body composition were not standard at the clinic, efforts are underway to implement bioimpedance analysis or abdominal circumference measurement for improved monitoring.</p>
<p id="Par40">Polycythemia, or erythrocytosis, is a common finding in patients using androgens, marked by elevated hematocrit (&gt; 49% for men) or hemoglobin (&gt; 165 g/L for men) [<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>]. This can contribute to increased cardiovascular risk through complications like microvascular issues and thrombotic events [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>, <a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>, <a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>]. There is currently no clear clinical guidance for managing polycythemia in those using supraphysiologic androgen doses, so regular monitoring for symptoms (such as headaches, visual changes, hypertension, and splenomegaly) is important [<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>, <a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>]. Hematocrit and blood pressure should be checked periodically. For hematocrit levels above 52%, a reduction in androgen dose or bloodletting may be considered to lower cardiovascular risk [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>]. We advocate for accessible phlebotomy when the hematocrit exceeds 52%, especially if the patient is symptomatic or has a hematocrit above 54%. Other contributors, such as diuretics, stimulant use, and dehydration, can further exacerbate polycythemia [<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>]. Persistent cases warrant evaluation for alternative causes (e.g., polycythemia vera; Jak2 mutation status). Obstructive sleep apnea (OSA) may also play a role and should be screened using tools like the STOP-BANG questionnaire [<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>, <a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>]. Although therapeutic phlebotomy is sometimes used for androgen-induced erythrocytosis, its efficacy and safety remain unclear, and risks such as iron depletion, which may increase thrombotic risk, must be weighed with the patient [<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>].</p>
<p id="Par41">Splenomegaly in this patient may have resulted from several converging factors. While long-term polycythemia secondary to androgen use possibly promoted myeloproliferative processes, it is also important to consider that HIV infection, present in this individual, can independently contribute to splenic enlargement through chronic immune activation [<a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>]. Furthermore, a history of growth hormone use could induce visceromegaly, further compounding splenic enlargement [<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>]. In this case, alternative causes of splenomegaly such as neoplastic, infectious, or congestive etiologies, including Polycythemia vera, were deemed less likely, and no further investigations (e.g., JAK2 mutation status) were pursued.</p></section><section id="Sec17"><h3 class="pmc_sec_title">Anabolic steroid-induced hypogonadism</h3>
<p id="Par42">The development of ASIH after use of androgens, a central or secondary form of the male hypogonadism by inhibition of the hypothalamic-pituitary–gonadal hormone axis, appears to be a hallmark in the pathology of this dependence syndrome and results in a functional incompetence of the testes with subnormal or impaired testosterone levels [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>, <a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>, <a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>, <a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>]. Furthermore, studies suggest possibly irreversible down-regulation of androgen receptors or androgen receptor signaling mechanisms, possibly representing end-organ resistance as well as direct testicular toxicity from synthetic androgen use, leading to possible irreversible primary hypogonadism or gonadal failure [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>, <a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. ASIH may cause potentially serious negative consequences in males, contributing to a unique withdrawal syndrome after androgen cessation, associated with dependency as well as potentially long-lasting and/or permanent symptoms [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. There is currently limited evidence on therapeutic approaches to facilitate safe withdrawal. Yet, many people still tend to self-treat this withdrawal syndrome through a practice often referred to as “post-cycle therapy” or ‘PCT’ [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>, <a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>]. PCT is a non-medical term used by men using androgens to describe a heterogeneous group of substances used based on anecdotal patterns, most often comprising of a course of human chorionic gonadotrophin (hCG), and/or selective estrogen receptor modulators (SERM) or aromatase inhibitors (AI) [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>, <a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>, <a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. Current protocols for treating anabolic steroid-induced hypogonadism (ASIH) rely on expert opinion and limited studies [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>, <a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>, <a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>, <a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>]. While some benefits have been shown, key questions—such as the proper hCG dosage—remain unresolved, with practices varying from 1000 to 3000 IU three times weekly; in Switzerland, 2000 IU is a standard dose. Robust randomized controlled trials are needed to guide dosing and long-term management, ensuring evidence-based care. There is emerging and conflicting literature on the provision of this endocrine therapy regarding the effectiveness as well as on the recovery of testicular function following AAS cessation. Among long-term users of androgens, withdrawal symptoms appear to be very common, frequently prolonged, associated with morbidity, and in many cases the full biochemical recovery is highly variable, often difficult to achieve and in some cases may never fully recover [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>, <a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>, <a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>, <a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>, <a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>, <a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>, <a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>, <a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>]. Medical and pharmacological interventions may support the recovery, although the recovery of ASIH may depend on many factors (e.g., age, degree of androgen use) [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>, <a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>]. We support the provision of these current strategies with caution and clear inclusion criteria, as these treatments are also well tolerated based on the current best medical literature, or absence thereof [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>, <a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>, <a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>, <a href="#CR62" class="usa-link" aria-describedby="CR62">62</a>–<a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>]. In patients where recovery of testosterone production is unsuccessful, substitution therapy with TRT should be introduced as standard medical care when clinically indicated. Unfortunately, current evidence does not provide clear guidance on the optimal duration to wait for spontaneous recovery. In this case, shared decision making played a crucial role and was based on a comprehensive evaluation of clinical and laboratory findings, the progression of symptoms, and the risk of relapse into non-medical androgen use.</p></section><section id="Sec18"><h3 class="pmc_sec_title">The role of primary care</h3>
<p id="Par43">The tragic outcome in this case—a patient’s death despite cessation of androgen use and harm reduction efforts—emphasizes the urgent necessity for early, low-threshold access to comprehensive, integrated medical services. Timely intervention through accessible and coordinated care is essential to identify, monitor, and address the complex health risks associated with non-medical androgen use before irreversible harm occurs. This case powerfully illustrates that without prompt engagement in integrated medical support, the window for preventing fatal outcomes may close all too soon. The primary care setting offers low-threshold access to healthcare, chronic care management, and care coordination. A case finding through low-threshold access (i.e., the patient’s wish for a laboratory check in our case) resulted in a timely diagnosis and management of cardiovascular risk factors, which may be crucial for the possible reversibility of ASIC and the prevention of possible detrimental cardiovascular health outcomes among this population. As demonstrated in this patient, the provision of harm-reducing measures within these settings allows people who use these substances to engage with (addiction) medical and behavioral interventions and to reduce these risks as well as the risk of relapse, instead of leaving patients in the care of peers without medical backgrounds. There is currently a lack of guidance and consensus on the optimal provision of harm-reducing measures. Future studies should focus on optimizing the clinical guidance for optimal care provision to people who use androgens in recreational sports in primary care settings. Importantly, the delivery of medical care often involves legal aspects that need to be considered and may instill fear regarding legal repercussions in both the treating doctor and the patient, which limits having an open discussion regarding this substance use [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>, <a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>, <a href="#CR66" class="usa-link" aria-describedby="CR66">66</a>]. Considering the patient's death, it becomes even more critical to implement strategies that avert both morbidity and mortality among individuals with a history of non-medical androgen use. Proactive identification, harm reduction, and timely intervention are crucial to addressing the profound risks faced by this population and to preventing such devastating outcomes in the future.</p></section></section><section id="Sec19"><h2 class="pmc_sec_title">Conclusions</h2>
<p id="Par44">Despite comprehensive, evidence-based clinical management, this young male patient with a history of recreational sports participation, long-term non-medical androgen use, HIV infection, and growth hormone supplementation ultimately died of a cardiovascular event. His care included cessation of androgens, initiation of endocrine treatment for ASIH with a 16-week protocol of tamoxifen, testosterone gel, and hCG, followed by substitution-based TRT, all provided within an integrated framework of medical, psychiatric, and addiction care. Additionally, his management involved thorough screening for comorbid medical conditions and active treatment of polycythemia. Although guideline-directed medical therapy led to normalization of cardiac structures and function, this case tragically mirrors the high risk of cardiovascular death among non-medical androgen users. This outcome underscores the urgent need for enhanced prevention, early intervention, and harm-reduction strategies to help reduce morbidity and prevent fatal deaths among individuals using androgens.</p>
<section id="Sec20"><h3 class="pmc_sec_title">Learning points</h3>
<ul class="list" style="list-style-type:disc">
<li><p id="Par46">Early harm reduction is vital: Timely initiation of comprehensive harm-reduction strategies in primary care is crucial to possibly prevent irreversible health consequences and fatal outcomes among individuals using non-medical androgens.</p></li>
<li><p id="Par47">Integrated care may improve outcomes: Coordinated, multidisciplinary management—including medical, psychiatric, and addiction support—may enhance engagement and recovery, addressing both substance dependence and associated health risks.</p></li>
<li><p id="Par48">Cardiovascular and hematologic risks can be substantial: Non-medical androgen use can result in severe complications, such as androgen-induced secondary polycythemia, cardiomyopathy, and cardiovascular events, which require early identification and intervention to avoid long-term damage.</p></li>
<li><p id="Par49">Management of ASIH is challenging: ASIH is common, often persistent, and requires individualized management; clear clinical protocols and evidence-based guidance are currently lacking and urgently needed regarding the high and increasing prevalence of this substance use.</p></li>
<li><p id="Par50">Primary care is a critical access point to healthcare services: Low-threshold, accessible primary care settings are essential for case finding, chronic disease monitoring, coordination of care, and provision of harm-reducing interventions to engage this high-risk population in ongoing care.</p></li>
</ul></section><section id="Sec21"><h3 class="pmc_sec_title">Patient perspective</h3>
<p id="Par51">I'm 39 years old now and started [androgen use] about 12–15 years ago. The reason to start was to increase [physical] performance and for faster increase in muscle mass. Since I didn't feel any major side effects other than sleep problems, there was no reason to stop [androgen use]. The family doctor had already diagnosed high blood pressure and too much blood [polycythemia] and discussed it with me, but that was it. There was no treatment or anything like that. There are no heart problems in my family, and I have never had any problems with it [heart]. I didn't notice many symptoms. The diagnosis described above [polycythemia] was made through a regular blood exam.</p>
<p id="Par52">Finally, I talked to friends who heard about the program [medical consultation for users of anabolic androgenic steroids] at Arud [primary care practice] and I signed up. Additional tests were carried out there and I was then referred to a specialist [outpatient cardiology clinic]. I was told about it [cardiomyopathy] by the Heart Clinic, Dr. H. Hammer, and was prescribed the drug Lisitril 5 mg [Lisinopril; ACE inhibitor] for 6 months. However, after about 4 months I had to stop taking the medication because my high blood pressure was too low! After another examination, it was determined that the heart muscle had recovered, and I no longer had to take the medication. I am no longer being treated for heart issues. In this regard, I also feel good and healthy! No further investigations are planned.</p>
<p id="Par53">I'm sure it was important and right that I sought medical advice and agreed to it. Ultimately, you can convince yourself that you are healthy for a long time, but only the doctors can determine what your insides really look like. I also have to say that I had great trust in everyone involved and I would like to thank you very much for that!</p></section></section><section id="Sec22"><h2 class="pmc_sec_title">Supplementary Information</h2>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12369084/bin/12954_2025_1294_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1.</a><sup> (216.9KB, docx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>We would like to express our sincere gratitude to Prof. Dr. med. Stefan Weiler (specialist in general internal medicine and clinical pharmacology and toxicology) for his expert pharmacologic and toxicologic assessment conducted post-mortem in relation to this case report. His invaluable insights and specialized analysis greatly contributed to the depth and rigor of our findings.</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>AMS Questionnaire</dt>
<dd><p id="Par4">Aging males' symptoms questionnaire</p></dd>
<dt>ASIC</dt>
<dd><p id="Par5">Anabolic steroid-induced cardiomyopathy</p></dd>
<dt>ASIH</dt>
<dd><p id="Par6">Anabolic-steroid-induced hypogonadism</p></dd>
<dt>CARE</dt>
<dd><p id="Par7">CAse REport (Checklist for case report information)</p></dd>
<dt>ECG</dt>
<dd><p id="Par8">Electrocardiogram</p></dd>
<dt>fT</dt>
<dd><p id="Par9">Free testosterone</p></dd>
<dt>hCG</dt>
<dd><p id="Par10">Human chorionic gonadotropin</p></dd>
<dt>HIV</dt>
<dd><p id="Par11">Human immunodeficiency virus</p></dd>
<dt>JAK2</dt>
<dd><p id="Par12">Janus kinase 2</p></dd>
<dt>LH</dt>
<dd><p id="Par13">Luteinizing hormone</p></dd>
<dt>OSA</dt>
<dd><p id="Par14">Obstructive sleep apnea</p></dd>
<dt>PCT</dt>
<dd><p id="Par15">Post-cycle therapy</p></dd>
<dt>tT</dt>
<dd><p id="Par16">Total testosterone</p></dd>
<dt>TRT</dt>
<dd><p id="Par17">Testosterone replacement therapy</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>RM/PB/OS conceived of the case report. RM/SLB conducted the literature search. RM/SLB extracted patient information. HH/JC provided specialised medical expertise. OS provided methodological expertise on primary care. RM prepared figures. RM created the main manuscript draft. All authors contributed to refinement and approved the final manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>No funding was received for conducting this study.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>The datasets supporting the conclusions of this article are included within the article and its additional files.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par54">This case report does not require ethical approval.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par55">The patient has read the final manuscript for initial submission and provided informed consent for publication.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par56">The authors have no relevant financial or non-financial interests to disclose. We can report that there is no conflict of interest.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher's Note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Ip EJ, Lu DH, Barnett MJ, Tenerowicz MJ, Vo JC, Perry PJ. Psychological and physical impact of anabolic-androgenic steroid dependence. Pharmacotherapy. 2012;32(10):910–9.
</cite> [<a href="https://doi.org/10.1002/j.1875-9114.2012.01123" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23033230/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ip%20EJ,%20Lu%20DH,%20Barnett%20MJ,%20Tenerowicz%20MJ,%20Vo%20JC,%20Perry%20PJ.%20Psychological%20and%20physical%20impact%20of%20anabolic-androgenic%20steroid%20dependence.%20Pharmacotherapy.%202012;32(10):910%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Bonnecaze AK, O’Connor T, Burns CA. Harm reduction in male patients actively using anabolic androgenic steroids (AAS) and performance-enhancing drugs (PEDs): a review. J Gen Intern Med. 2021;36(7):2055–64.
</cite> [<a href="https://doi.org/10.1007/s11606-021-06751-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8298654/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33948794/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bonnecaze%20AK,%20O%E2%80%99Connor%20T,%20Burns%20CA.%20Harm%20reduction%20in%20male%20patients%20actively%20using%20anabolic%20androgenic%20steroids%20(AAS)%20and%20performance-enhancing%20drugs%20(PEDs):%20a%20review.%20J%20Gen%20Intern%20Med.%202021;36(7):2055%E2%80%9364." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Bonnecaze AK, O’Connor T, Aloi JA. Characteristics and attitudes of men using anabolic androgenic steroids (AAS): a survey of 2385 men. Am J Mens Health. 2020;14(6): 1557988320966536.
</cite> [<a href="https://doi.org/10.1177/1557988320966536" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7739101/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33307930/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bonnecaze%20AK,%20O%E2%80%99Connor%20T,%20Aloi%20JA.%20Characteristics%20and%20attitudes%20of%20men%20using%20anabolic%20androgenic%20steroids%20(AAS):%20a%20survey%20of%202385%20men.%20Am%20J%20Mens%20Health.%202020;14(6):%201557988320966536." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Kanayama G, Pope HG. History and epidemiology of anabolic androgens in athletes and non-athletes. Mol Cell Endocrinol. 2018;464:4–13.
</cite> [<a href="https://doi.org/10.1016/j.mce.2017.02.039" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28245998/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kanayama%20G,%20Pope%20HG.%20History%20and%20epidemiology%20of%20anabolic%20androgens%20in%20athletes%20and%20non-athletes.%20Mol%20Cell%20Endocrinol.%202018;464:4%E2%80%9313." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Mullen C, Whalley BJ, Schifano F, Baker JS. Anabolic androgenic steroid abuse in the United Kingdom: an update. Br J Pharmacol. 2020. 10.1111/bph.14995.
</cite> [<a href="https://doi.org/10.1111/bph.14995" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7174889/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31989581/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mullen%20C,%20Whalley%20BJ,%20Schifano%20F,%20Baker%20JS.%20Anabolic%20androgenic%20steroid%20abuse%20in%20the%20United%20Kingdom:%20an%20update.%20Br%20J%20Pharmacol.%202020.%2010.1111/bph.14995." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Nieschlag E, Vorona E. Doping with anabolic androgenic steroids (AAS): adverse effects on non-reproductive organs and functions. Rev Endocr Metab Disord. 2015;16(3):199–211.
</cite> [<a href="https://doi.org/10.1007/s11154-015-9320-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26373946/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nieschlag%20E,%20Vorona%20E.%20Doping%20with%20anabolic%20androgenic%20steroids%20(AAS):%20adverse%20effects%20on%20non-reproductive%20organs%20and%20functions.%20Rev%20Endocr%20Metab%20Disord.%202015;16(3):199%E2%80%93211." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Christou MA, Christou PA, Markozannes G, Tsatsoulis A, Mastorakos G, Tigas S. Effects of anabolic androgenic steroids on the reproductive system of athletes and recreational users: a systematic review and meta-analysis. Sports Med. 2017;47(9):1869–83.
</cite> [<a href="https://doi.org/10.1007/s40279-017-0709-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28258581/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Christou%20MA,%20Christou%20PA,%20Markozannes%20G,%20Tsatsoulis%20A,%20Mastorakos%20G,%20Tigas%20S.%20Effects%20of%20anabolic%20androgenic%20steroids%20on%20the%20reproductive%20system%20of%20athletes%20and%20recreational%20users:%20a%20systematic%20review%20and%20meta-analysis.%20Sports%20Med.%202017;47(9):1869%E2%80%9383." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Windfeld-Mathiasen J, Heerfordt IM, Dalhoff KP, Trærup Andersen J, Andersen MA, Johansson KS, et al. Cardiovascular disease in anabolic androgenic steroid users. Circulation. 2025;151:828–34.
</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.124.071117" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39945117/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Windfeld-Mathiasen%20J,%20Heerfordt%20IM,%20Dalhoff%20KP,%20Tr%C3%A6rup%20Andersen%20J,%20Andersen%20MA,%20Johansson%20KS,%20et%20al.%20Cardiovascular%20disease%20in%20anabolic%20androgenic%20steroid%20users.%20Circulation.%202025;151:828%E2%80%9334." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Albano GD, Amico F, Cocimano G, Liberto A, Maglietta F, Esposito M, et al. Adverse effects of anabolic-androgenic steroids: a literature review. Healthcare. 2021;9(1): 97.
</cite> [<a href="https://doi.org/10.3390/healthcare9010097" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7832337/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33477800/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Albano%20GD,%20Amico%20F,%20Cocimano%20G,%20Liberto%20A,%20Maglietta%20F,%20Esposito%20M,%20et%20al.%20Adverse%20effects%20of%20anabolic-androgenic%20steroids:%20a%20literature%20review.%20Healthcare.%202021;9(1):%2097." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Esposito M, Salerno M, Calvano G, Agliozzo R, Ficarra V, Sessa F, et al. Impact of anabolic androgenic steroids on male sexual and reproductive function: a systematic review. Panminerva Med. 2023;65(1):43–50.
</cite> [<a href="https://doi.org/10.23736/S0031-0808.22.04677-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35146992/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Esposito%20M,%20Salerno%20M,%20Calvano%20G,%20Agliozzo%20R,%20Ficarra%20V,%20Sessa%20F,%20et%20al.%20Impact%20of%20anabolic%20androgenic%20steroids%20on%20male%20sexual%20and%20reproductive%20function:%20a%20systematic%20review.%20Panminerva%20Med.%202023;65(1):43%E2%80%9350." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Fadah K, Gopi G, Lingireddy A, Blumer V, Dewald T, Mentz RJ. Anabolic androgenic steroids and cardiomyopathy: an update. Front Cardiovasc Med. 2023;10: 1214374.
</cite> [<a href="https://doi.org/10.3389/fcvm.2023.1214374" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10412093/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37564909/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fadah%20K,%20Gopi%20G,%20Lingireddy%20A,%20Blumer%20V,%20Dewald%20T,%20Mentz%20RJ.%20Anabolic%20androgenic%20steroids%20and%20cardiomyopathy:%20an%20update.%20Front%20Cardiovasc%20Med.%202023;10:%201214374." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Pope HG, Kanayama G, Athey A, Ryan E, Hudson JI, Baggish A. The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates. Am J Addict. 2014;23(4):371–7.
</cite> [<a href="https://doi.org/10.1111/j.1521-0391.2013.12118.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3961570/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24112239/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pope%20HG,%20Kanayama%20G,%20Athey%20A,%20Ryan%20E,%20Hudson%20JI,%20Baggish%20A.%20The%20lifetime%20prevalence%20of%20anabolic-androgenic%20steroid%20use%20and%20dependence%20in%20Americans:%20current%20best%20estimates.%20Am%20J%20Addict.%202014;23(4):371%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Skauen JE, Pallesen S, Bjørnebekk A, Chegeni R, Syvertsen A, Petróczi A, et al. Prevalence and correlates of androgen dependence: a meta-analysis, meta-regression analysis and qualitative synthesis. Curr Opin Endocrinol Diabetes Obes. 2023. 10.1097/MED.0000000000000822.
</cite> [<a href="https://doi.org/10.1097/MED.0000000000000822" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37410490/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Skauen%20JE,%20Pallesen%20S,%20Bj%C3%B8rnebekk%20A,%20Chegeni%20R,%20Syvertsen%20A,%20Petr%C3%B3czi%20A,%20et%20al.%20Prevalence%20and%20correlates%20of%20androgen%20dependence:%20a%20meta-analysis,%20meta-regression%20analysis%20and%20qualitative%20synthesis.%20Curr%20Opin%20Endocrinol%20Diabetes%20Obes.%202023.%2010.1097/MED.0000000000000822." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Rahnema CD, Lipshultz LI, Crosnoe LE, Kovac JR, Kim ED. Anabolic steroid-induced hypogonadism: diagnosis and treatment. Fertil Steril. 2014;101(5):1271–9.
</cite> [<a href="https://doi.org/10.1016/j.fertnstert.2014.02.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24636400/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rahnema%20CD,%20Lipshultz%20LI,%20Crosnoe%20LE,%20Kovac%20JR,%20Kim%20ED.%20Anabolic%20steroid-induced%20hypogonadism:%20diagnosis%20and%20treatment.%20Fertil%20Steril.%202014;101(5):1271%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Solanki P, Eu B, Smith J, Allan C, Lee K. Physical, psychological and biochemical recovery from anabolic steroid-induced hypogonadism: a scoping review. Endocr Connect. 2023. 10.1530/EC-23-0358.
</cite> [<a href="https://doi.org/10.1530/EC-23-0358" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10620455/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37855241/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Solanki%20P,%20Eu%20B,%20Smith%20J,%20Allan%20C,%20Lee%20K.%20Physical,%20psychological%20and%20biochemical%20recovery%20from%20anabolic%20steroid-induced%20hypogonadism:%20a%20scoping%20review.%20Endocr%20Connect.%202023.%2010.1530/EC-23-0358." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Magnolini R, Kossinna K, Bjasch D, Kruijver M, Bruggmann P, Senn O. Feasibility of implementing current best clinical practice for people who are using anabolic androgenic steroids within a Swiss primary care practice: a quality assurance study. Swiss Med Wkly. 2025;155(2): 4225. 10.57187/s.4225.
</cite> [<a href="https://doi.org/10.57187/s.4225" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39977451/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Magnolini%20R,%20Kossinna%20K,%20Bjasch%20D,%20Kruijver%20M,%20Bruggmann%20P,%20Senn%20O.%20Feasibility%20of%20implementing%20current%20best%20clinical%20practice%20for%20people%20who%20are%20using%20anabolic%20androgenic%20steroids%20within%20a%20Swiss%20primary%20care%20practice:%20a%20quality%20assurance%20study.%20Swiss%20Med%20Wkly.%202025;155(2):%204225.%2010.57187/s.4225." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D. The CARE guidelines: consensus-based clinical case reporting guideline development. Headache. 2013;53(10):1541–7.
</cite> [<a href="https://doi.org/10.1111/head.12246" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24266334/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gagnier%20JJ,%20Kienle%20G,%20Altman%20DG,%20Moher%20D,%20Sox%20H,%20Riley%20D.%20The%20CARE%20guidelines:%20consensus-based%20clinical%20case%20reporting%20guideline%20development.%20Headache.%202013;53(10):1541%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Grant B, Kean J, Vali N, Campbell J, Maden L, Bijral P, et al. The use of post-cycle therapy is associated with reduced withdrawal symptoms from anabolic-androgenic steroid use: a survey of 470 men. Subst Abuse Treat Prev Policy. 2023;18(1): 66.
</cite> [<a href="https://doi.org/10.1186/s13011-023-00573-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10640727/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37951896/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Grant%20B,%20Kean%20J,%20Vali%20N,%20Campbell%20J,%20Maden%20L,%20Bijral%20P,%20et%20al.%20The%20use%20of%20post-cycle%20therapy%20is%20associated%20with%20reduced%20withdrawal%20symptoms%20from%20anabolic-androgenic%20steroid%20use:%20a%20survey%20of%20470%20men.%20Subst%20Abuse%20Treat%20Prev%20Policy.%202023;18(1):%2066." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Grant B, Campbell J, Pradeep A, Burns AD, Bassett P, Abbara A, et al. Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study. Eur J Endocrinol. 2023;189(6):601–10.
</cite> [<a href="https://doi.org/10.1093/ejendo/lvad164" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38102386/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Grant%20B,%20Campbell%20J,%20Pradeep%20A,%20Burns%20AD,%20Bassett%20P,%20Abbara%20A,%20et%20al.%20Factors%20predicting%20normalization%20of%20reproductive%20hormones%20after%20cessation%20of%20anabolic-androgenic%20steroids%20in%20men:%20a%20single%20center%20retrospective%20study.%20Eur%20J%20Endocrinol.%202023;189(6):601%E2%80%9310." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Zeeck A, Welter V, Alatas H, Hildebrandt T, Lahmann C, Hartmann A. Muscle dysmorphic disorder inventory (MDDI): validation of a German version with a focus on gender. PLoS ONE. 2018;13(11): e0207535.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0207535" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6239320/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30444914/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zeeck%20A,%20Welter%20V,%20Alatas%20H,%20Hildebrandt%20T,%20Lahmann%20C,%20Hartmann%20A.%20Muscle%20dysmorphic%20disorder%20inventory%20(MDDI):%20validation%20of%20a%20German%20version%20with%20a%20focus%20on%20gender.%20PLoS%20ONE.%202018;13(11):%20e0207535." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG. Issues for DSM-V: clarifying the diagnostic criteria for anabolic-androgenic steroid dependence. Am J Psychiatry. 2009;166(6):642–5.
</cite> [<a href="https://doi.org/10.1176/appi.ajp.2009.08111699" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2696068/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19487399/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kanayama%20G,%20Brower%20KJ,%20Wood%20RI,%20Hudson%20JI,%20Pope%20HG.%20Issues%20for%20DSM-V:%20clarifying%20the%20diagnostic%20criteria%20for%20anabolic-androgenic%20steroid%20dependence.%20Am%20J%20Psychiatry.%202009;166(6):642%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45(38):3912–4018.
</cite> [<a href="https://doi.org/10.1093/eurheartj/ehae178" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39210715/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?McEvoy%20JW,%20McCarthy%20CP,%20Bruno%20RM,%20Brouwers%20S,%20Canavan%20MD,%20Ceconi%20C,%20et%20al.%202024%20ESC%20guidelines%20for%20the%20management%20of%20elevated%20blood%20pressure%20and%20hypertension.%20Eur%20Heart%20J.%202024;45(38):3912%E2%80%934018." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Heinemann LA, Saad F, Zimmermann T, Novak A, Myon E, Badia X, et al. The Aging Males’ Symptoms (AMS) scale: update and compilation of international versions. Health Qual Life Outcomes. 2003;1:15.
</cite> [<a href="https://doi.org/10.1186/1477-7525-1-15" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC155679/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12747807/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Heinemann%20LA,%20Saad%20F,%20Zimmermann%20T,%20Novak%20A,%20Myon%20E,%20Badia%20X,%20et%20al.%20The%20Aging%20Males%E2%80%99%20Symptoms%20(AMS)%20scale:%20update%20and%20compilation%20of%20international%20versions.%20Health%20Qual%20Life%20Outcomes.%202003;1:15." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Corona G, Goulis DG, Huhtaniemi I, Zitzmann M, Toppari J, Forti G, et al. European academy of andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males: endorsing organization: European Society of Endocrinology. Andrology. 2020;8(5):970–87.
</cite> [<a href="https://doi.org/10.1111/andr.12770" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32026626/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Corona%20G,%20Goulis%20DG,%20Huhtaniemi%20I,%20Zitzmann%20M,%20Toppari%20J,%20Forti%20G,%20et%20al.%20European%20academy%20of%20andrology%20(EAA)%20guidelines%20on%20investigation,%20treatment%20and%20monitoring%20of%20functional%20hypogonadism%20in%20males:%20endorsing%20organization:%20European%20Society%20of%20Endocrinology.%20Andrology.%202020;8(5):970%E2%80%9387." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Lincoff AM, Bhasin S, Flevaris P, Mitchell LM, Basaria S, Boden WE, et al. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023;389(2):107–17.
</cite> [<a href="https://doi.org/10.1056/NEJMoa2215025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37326322/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lincoff%20AM,%20Bhasin%20S,%20Flevaris%20P,%20Mitchell%20LM,%20Basaria%20S,%20Boden%20WE,%20et%20al.%20Cardiovascular%20safety%20of%20testosterone-replacement%20therapy.%20N%20Engl%20J%20Med.%202023;389(2):107%E2%80%9317." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>De Vincentis S, Rochira V. Update on acquired hypogonadism in men living with HIV: pathogenesis, clinic, and treatment. Front Endocrinol (Lausanne). 2023;14: 1201696.
</cite> [<a href="https://doi.org/10.3389/fendo.2023.1201696" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10338827/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37455928/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?De%20Vincentis%20S,%20Rochira%20V.%20Update%20on%20acquired%20hypogonadism%20in%20men%20living%20with%20HIV:%20pathogenesis,%20clinic,%20and%20treatment.%20Front%20Endocrinol%20(Lausanne).%202023;14:%201201696." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Afolabi JM, Kirabo A. HIV and cardiovascular disease. Circ Res. 2024;134(11):1512–4.
</cite> [<a href="https://doi.org/10.1161/CIRCRESAHA.124.324805" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11132120/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38781297/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Afolabi%20JM,%20Kirabo%20A.%20HIV%20and%20cardiovascular%20disease.%20Circ%20Res.%202024;134(11):1512%E2%80%934." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Parente Filho SLA, Gomes PEAC, Forte GA, Lima LLL, Silva Júnior GBD, Meneses GC, et al. Kidney disease associated with androgenic-anabolic steroids and vitamin supplements abuse: be aware! Nefrologia (Engl Ed). 2020;40(1):26–31.
</cite> [<a href="https://doi.org/10.1016/j.nefro.2019.06.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31585781/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Parente%20Filho%20SLA,%20Gomes%20PEAC,%20Forte%20GA,%20Lima%20LLL,%20Silva%20J%C3%BAnior%20GBD,%20Meneses%20GC,%20et%20al.%20Kidney%20disease%20associated%20with%20androgenic-anabolic%20steroids%20and%20vitamin%20supplements%20abuse:%20be%20aware!%20Nefrologia%20(Engl%20Ed).%202020;40(1):26%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Smoliga JM, Wilber ZT, Robinson BT. Premature death in bodybuilders: what do we know? Sports Med. 2023;53(5):933–48.
</cite> [<a href="https://doi.org/10.1007/s40279-022-01801-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9885939/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36715876/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Smoliga%20JM,%20Wilber%20ZT,%20Robinson%20BT.%20Premature%20death%20in%20bodybuilders:%20what%20do%20we%20know?%20Sports%20Med.%202023;53(5):933%E2%80%9348." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Magnolini R, Falcato L, Cremonesi A, Schori D, Bruggmann P. Fake anabolic androgenic steroids on the black market - a systematic review and meta-analysis on qualitative and quantitative analytical results found within the literature. BMC Public Health. 2022;22(1): 1371.
</cite> [<a href="https://doi.org/10.1186/s12889-022-13734-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9288681/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35842594/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Magnolini%20R,%20Falcato%20L,%20Cremonesi%20A,%20Schori%20D,%20Bruggmann%20P.%20Fake%20anabolic%20androgenic%20steroids%20on%20the%20black%20market%20-%20a%20systematic%20review%20and%20meta-analysis%20on%20qualitative%20and%20quantitative%20analytical%20results%20found%20within%20the%20literature.%20BMC%20Public%20Health.%202022;22(1):%201371." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Kruijver M, Bruggmann P, Magnolini R. Evidence of use and users of image- and performance-enhancing drugs in sports in Switzerland: a scoping literature review and implications for Swiss drug policy. Swiss Med Wkly. 2023;153: 40080.
</cite> [<a href="https://doi.org/10.57187/smw.2023.40080" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37245119/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kruijver%20M,%20Bruggmann%20P,%20Magnolini%20R.%20Evidence%20of%20use%20and%20users%20of%20image-%20and%20performance-enhancing%20drugs%20in%20sports%20in%20Switzerland:%20a%20scoping%20literature%20review%20and%20implications%20for%20Swiss%20drug%20policy.%20Swiss%20Med%20Wkly.%202023;153:%2040080." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Sagoe D, Molde H, Andreassen CS, Torsheim T, Pallesen S. The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Ann Epidemiol. 2014;24(5):383–98.
</cite> [<a href="https://doi.org/10.1016/j.annepidem.2014.01.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24582699/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sagoe%20D,%20Molde%20H,%20Andreassen%20CS,%20Torsheim%20T,%20Pallesen%20S.%20The%20global%20epidemiology%20of%20anabolic-androgenic%20steroid%20use:%20a%20meta-analysis%20and%20meta-regression%20analysis.%20Ann%20Epidemiol.%202014;24(5):383%E2%80%9398." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Iff S, Butzke I, Quednow B, Gupta R, Imboden C, Claussen M. «Image and performance enhancing drugs» im Freizeitsport. Swiss Med Forum. 2021;21:843–7.</cite> [<a href="https://scholar.google.com/scholar_lookup?Iff%20S,%20Butzke%20I,%20Quednow%20B,%20Gupta%20R,%20Imboden%20C,%20Claussen%20M.%20%C2%ABImage%20and%20performance%20enhancing%20drugs%C2%BB%20im%20Freizeitsport.%20Swiss%20Med%20Forum.%202021;21:843%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG. Anabolic-androgenic steroid dependence: an emerging disorder. Addiction. 2009;104(12):1966–78.
</cite> [<a href="https://doi.org/10.1111/j.1360-0443.2009.02734.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2780436/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19922565/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kanayama%20G,%20Brower%20KJ,%20Wood%20RI,%20Hudson%20JI,%20Pope%20HG.%20Anabolic-androgenic%20steroid%20dependence:%20an%20emerging%20disorder.%20Addiction.%202009;104(12):1966%E2%80%9378." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Szalavitz M, Rigg KK, Wakeman SE. Drug dependence is not addiction-and it matters. Ann Med. 2021;53(1):1989–92.
</cite> [<a href="https://doi.org/10.1080/07853890.2021.1995623" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8583742/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34751058/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Szalavitz%20M,%20Rigg%20KK,%20Wakeman%20SE.%20Drug%20dependence%20is%20not%20addiction-and%20it%20matters.%20Ann%20Med.%202021;53(1):1989%E2%80%9392." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Horowitz MA, Taylor D. Addiction and physical dependence are not the same thing. Lancet Psychiatry. 2023;10(8):e23.
</cite> [<a href="https://doi.org/10.1016/S2215-0366(23)00230-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37479345/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Horowitz%20MA,%20Taylor%20D.%20Addiction%20and%20physical%20dependence%20are%20not%20the%20same%20thing.%20Lancet%20Psychiatry.%202023;10(8):e23." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Harvey O, Keen S, Parrish M, van Teijlingen E. Support for people who use anabolic androgenic steroids: a systematic scoping review into what they want and what they access. BMC Public Health. 2019;19(1): 1024.
</cite> [<a href="https://doi.org/10.1186/s12889-019-7288-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6670144/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31366349/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Harvey%20O,%20Keen%20S,%20Parrish%20M,%20van%20Teijlingen%20E.%20Support%20for%20people%20who%20use%20anabolic%20androgenic%20steroids:%20a%20systematic%20scoping%20review%20into%20what%20they%20want%20and%20what%20they%20access.%20BMC%20Public%20Health.%202019;19(1):%201024." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Horwitz H, Andersen JT, Dalhoff KP. Health consequences of androgenic anabolic steroid use. J Intern Med. 2019;285(3):333–40.
</cite> [<a href="https://doi.org/10.1111/joim.12850" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30460728/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Horwitz%20H,%20Andersen%20JT,%20Dalhoff%20KP.%20Health%20consequences%20of%20androgenic%20anabolic%20steroid%20use.%20J%20Intern%20Med.%202019;285(3):333%E2%80%9340." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>McCullough D, Webb R, Enright KJ, Lane KE, McVeigh J, Stewart CE, et al. How the love of muscle can break a heart: impact of anabolic androgenic steroids on skeletal muscle hypertrophy, metabolic and cardiovascular health. Rev Endocr Metab Disord. 2021;22(2):389–405.
</cite> [<a href="https://doi.org/10.1007/s11154-020-09616-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8087567/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33269425/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?McCullough%20D,%20Webb%20R,%20Enright%20KJ,%20Lane%20KE,%20McVeigh%20J,%20Stewart%20CE,%20et%20al.%20How%20the%20love%20of%20muscle%20can%20break%20a%20heart:%20impact%20of%20anabolic%20androgenic%20steroids%20on%20skeletal%20muscle%20hypertrophy,%20metabolic%20and%20cardiovascular%20health.%20Rev%20Endocr%20Metab%20Disord.%202021;22(2):389%E2%80%93405." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Windfeld-Mathiasen J, Heerfordt IM, Dalhoff KP, Andersen JT, Horwitz H. Mortality among users of anabolic steroids. JAMA. 2024. 10.1001/jama.2024.3180.
</cite> [<a href="https://doi.org/10.1001/jama.2024.3180" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10941020/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38483396/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Windfeld-Mathiasen%20J,%20Heerfordt%20IM,%20Dalhoff%20KP,%20Andersen%20JT,%20Horwitz%20H.%20Mortality%20among%20users%20of%20anabolic%20steroids.%20JAMA.%202024.%2010.1001/jama.2024.3180." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Hernández-Guerra AI, Tapia J, Menéndez-Quintanal LM, Lucena JS. Sudden cardiac death in anabolic androgenic steroids abuse: case report and literature review. Forensic Sci Res. 2019;4(3):267–73.
</cite> [<a href="https://doi.org/10.1080/20961790.2019.1595350" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6713204/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31489392/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hern%C3%A1ndez-Guerra%20AI,%20Tapia%20J,%20Men%C3%A9ndez-Quintanal%20LM,%20Lucena%20JS.%20Sudden%20cardiac%20death%20in%20anabolic%20androgenic%20steroids%20abuse:%20case%20report%20and%20literature%20review.%20Forensic%20Sci%20Res.%202019;4(3):267%E2%80%9373." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Smit DL, Voogel AJ, den Heijer M, de Ronde W. Anabolic androgenic steroids induce reversible left ventricular hypertrophy and cardiac. Dysfunction echocardiography results of the HAARLEM study. Front Reprod Health. 2021;3:732318.
</cite> [<a href="https://doi.org/10.3389/frph.2021.732318" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9580689/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36304014/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Smit%20DL,%20Voogel%20AJ,%20den%20Heijer%20M,%20de%20Ronde%20W.%20Anabolic%20androgenic%20steroids%20induce%20reversible%20left%20ventricular%20hypertrophy%20and%20cardiac.%20Dysfunction%20echocardiography%20results%20of%20the%20HAARLEM%20study.%20Front%20Reprod%20Health.%202021;3:732318." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Doleeb S, Kratz A, Salter M, Thohan V. Strong muscles, weak heart: testosterone-induced cardiomyopathy. ESC Heart Fail. 2019;6(5):1000–4.
</cite> [<a href="https://doi.org/10.1002/ehf2.12494" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6816072/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31287235/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Doleeb%20S,%20Kratz%20A,%20Salter%20M,%20Thohan%20V.%20Strong%20muscles,%20weak%20heart:%20testosterone-induced%20cardiomyopathy.%20ESC%20Heart%20Fail.%202019;6(5):1000%E2%80%934." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Mohsenin V. Obstructive sleep apnea and hypertension: a critical review. Curr Hypertens Rep. 2014;16(10): 482.
</cite> [<a href="https://doi.org/10.1007/s11906-014-0482-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25139780/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mohsenin%20V.%20Obstructive%20sleep%20apnea%20and%20hypertension:%20a%20critical%20review.%20Curr%20Hypertens%20Rep.%202014;16(10):%20482." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Basheer B, Ila V, Barros R, Mesquita F, Lopes LS, Lima VFN, et al. Management of adverse effects in testosterone replacement therapy. Int Braz J Urol. 2025. 10.1590/s1677-5538.ibju.2025.9904.
</cite> [<a href="https://doi.org/10.1590/S1677-5538.IBJU.2025.9904" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12052019/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39908204/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Basheer%20B,%20Ila%20V,%20Barros%20R,%20Mesquita%20F,%20Lopes%20LS,%20Lima%20VFN,%20et%20al.%20Management%20of%20adverse%20effects%20in%20testosterone%20replacement%20therapy.%20Int%20Braz%20J%20Urol.%202025.%2010.1590/s1677-5538.ibju.2025.9904." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Lugo G, Pena L, Cordido F. Clinical manifestations and diagnosis of acromegaly. Int J Endocrinol. 2012;2012: 540398.
</cite> [<a href="https://doi.org/10.1155/2012/540398" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3296170/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22518126/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lugo%20G,%20Pena%20L,%20Cordido%20F.%20Clinical%20manifestations%20and%20diagnosis%20of%20acromegaly.%20Int%20J%20Endocrinol.%202012;2012:%20540398." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Baggish AL, Weiner RB, Kanayama G, Hudson JI, Lu MT, Hoffmann U, et al. Cardiovascular toxicity of illicit anabolic-androgenic steroid use. Circulation. 2017;135(21):1991–2002.
</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.116.026945" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5614517/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28533317/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Baggish%20AL,%20Weiner%20RB,%20Kanayama%20G,%20Hudson%20JI,%20Lu%20MT,%20Hoffmann%20U,%20et%20al.%20Cardiovascular%20toxicity%20of%20illicit%20anabolic-androgenic%20steroid%20use.%20Circulation.%202017;135(21):1991%E2%80%932002." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Drezner JA, Sharma S, Baggish A, Papadakis M, Wilson MG, Prutkin JM, et al. International criteria for electrocardiographic interpretation in athletes: consensus statement. Br J Sports Med. 2017;51(9):704–31.
</cite> [<a href="https://doi.org/10.1136/bjsports-2016-097331" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28258178/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Drezner%20JA,%20Sharma%20S,%20Baggish%20A,%20Papadakis%20M,%20Wilson%20MG,%20Prutkin%20JM,%20et%20al.%20International%20criteria%20for%20electrocardiographic%20interpretation%20in%20athletes:%20consensus%20statement.%20Br%20J%20Sports%20Med.%202017;51(9):704%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Drezner JA, Ackerman MJ, Anderson J, Ashley E, Asplund CA, Baggish AL, et al. Electrocardiographic interpretation in athletes: the “Seattle criteria.” Br J Sports Med. 2013;47(3):122–4.
</cite> [<a href="https://doi.org/10.1136/bjsports-2012-092067" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23303758/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Drezner%20JA,%20Ackerman%20MJ,%20Anderson%20J,%20Ashley%20E,%20Asplund%20CA,%20Baggish%20AL,%20et%20al.%20Electrocardiographic%20interpretation%20in%20athletes:%20the%20%E2%80%9CSeattle%20criteria.%E2%80%9D%20Br%20J%20Sports%20Med.%202013;47(3):122%E2%80%934." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Estes EH, Zhang ZM, Li Y, Tereschenko LG, Soliman EZ. The romhilt-estes left ventricular hypertrophy score and its components predict all-cause mortality in the general population. Am Heart J. 2015;170(1):104–9.
</cite> [<a href="https://doi.org/10.1016/j.ahj.2015.04.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4646417/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26093870/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Estes%20EH,%20Zhang%20ZM,%20Li%20Y,%20Tereschenko%20LG,%20Soliman%20EZ.%20The%20romhilt-estes%20left%20ventricular%20hypertrophy%20score%20and%20its%20components%20predict%20all-cause%20mortality%20in%20the%20general%20population.%20Am%20Heart%20J.%202015;170(1):104%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Courand PY, Lantelme P, Gosse P. Electrocardiographic detection of left ventricular hypertrophy: time to forget the Sokolow-Lyon index? Arch Cardiovasc Dis. 2015;108(5):277–80.
</cite> [<a href="https://doi.org/10.1016/j.acvd.2015.03.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25937357/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Courand%20PY,%20Lantelme%20P,%20Gosse%20P.%20Electrocardiographic%20detection%20of%20left%20ventricular%20hypertrophy:%20time%20to%20forget%20the%20Sokolow-Lyon%20index?%20Arch%20Cardiovasc%20Dis.%202015;108(5):277%E2%80%9380." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Pillai AA, Fazal S, Mukkamalla SKR, Babiker HM. Polycythemia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/30252337/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pillai%20AA,%20Fazal%20S,%20Mukkamalla%20SKR,%20Babiker%20HM.%20Polycythemia.%20In:%20StatPearls%20%5BInternet%5D.%20Treasure%20Island%20(FL):%20StatPearls%20Publishing;%202025." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Michiels JJ. Erythromelalgia and vascular complications in polycythemia vera. Semin Thromb Hemost. 1997;23(5):441–54.
</cite> [<a href="https://doi.org/10.1055/s-2007-996121" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9387203/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Michiels%20JJ.%20Erythromelalgia%20and%20vascular%20complications%20in%20polycythemia%20vera.%20Semin%20Thromb%20Hemost.%201997;23(5):441%E2%80%9354." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Chang S, Münster AB, Gram J, Sidelmann JJ. Anabolic androgenic steroid abuse: the effects on thrombosis risk, coagulation, and fibrinolysis. Semin Thromb Hemost. 2018;44(8):734–46.
</cite> [<a href="https://doi.org/10.1055/s-0038-1670639" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30267392/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chang%20S,%20M%C3%BCnster%20AB,%20Gram%20J,%20Sidelmann%20JJ.%20Anabolic%20androgenic%20steroid%20abuse:%20the%20effects%20on%20thrombosis%20risk,%20coagulation,%20and%20fibrinolysis.%20Semin%20Thromb%20Hemost.%202018;44(8):734%E2%80%9346." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR55">
<span class="label">55.</span><cite>Ohlander SJ, Varghese B, Pastuszak AW. Erythrocytosis following testosterone therapy. Sex Med Rev. 2018;6(1):77–85.
</cite> [<a href="https://doi.org/10.1016/j.sxmr.2017.04.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5690890/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28526632/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ohlander%20SJ,%20Varghese%20B,%20Pastuszak%20AW.%20Erythrocytosis%20following%20testosterone%20therapy.%20Sex%20Med%20Rev.%202018;6(1):77%E2%80%9385." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Bond P, Verdegaal T, Smit DL. Testosterone therapy-induced erythrocytosis: can phlebotomy be justified? Endocr Connect. 2024;13(10):e240283.
</cite> [<a href="https://doi.org/10.1530/EC-24-0283" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11466264/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39212549/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bond%20P,%20Verdegaal%20T,%20Smit%20DL.%20Testosterone%20therapy-induced%20erythrocytosis:%20can%20phlebotomy%20be%20justified?%20Endocr%20Connect.%202024;13(10):e240283." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>Furrer H. Prevalence and clinical significance of splenomegaly in asymptomatic human immunodeficiency virus type 1-infected adults. Swiss HIV cohort study. Clin Infect Dis. 2000;30(6):943–5.
</cite> [<a href="https://doi.org/10.1086/313816" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10880308/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Furrer%20H.%20Prevalence%20and%20clinical%20significance%20of%20splenomegaly%20in%20asymptomatic%20human%20immunodeficiency%20virus%20type%201-infected%20adults.%20Swiss%20HIV%20cohort%20study.%20Clin%20Infect%20Dis.%202000;30(6):943%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>Vilar Neto JO, da Silva CA, Bruno da Silva CA, Pinto DV, Caminha JSR, de Matos RS, et al. Anabolic androgenic steroid-induced hypogonadism, a reversible condition in male individuals? A systematic review. Andrologia. 2021;53(7):e14062.
</cite> [<a href="https://doi.org/10.1111/and.14062" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33887077/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vilar%20Neto%20JO,%20da%20Silva%20CA,%20Bruno%20da%20Silva%20CA,%20Pinto%20DV,%20Caminha%20JSR,%20de%20Matos%20RS,%20et%20al.%20Anabolic%20androgenic%20steroid-induced%20hypogonadism,%20a%20reversible%20condition%20in%20male%20individuals?%20A%20systematic%20review.%20Andrologia.%202021;53(7):e14062." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>van Breda E, Keizer HA, Kuipers H, Wolffenbuttel BH. Androgenic anabolic steroid use and severe hypothalamic-pituitary dysfunction: a case study. Int J Sports Med. 2003;24(3):195–6.
</cite> [<a href="https://doi.org/10.1055/s-2003-39089" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12740738/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?van%20Breda%20E,%20Keizer%20HA,%20Kuipers%20H,%20Wolffenbuttel%20BH.%20Androgenic%20anabolic%20steroid%20use%20and%20severe%20hypothalamic-pituitary%20dysfunction:%20a%20case%20study.%20Int%20J%20Sports%20Med.%202003;24(3):195%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>Havnes IA, Henriksen HCB, Johansen PW, Bjørnebekk A, Neupane SP, Hisdal J, et al. Off-label use of clomiphene citrate to treat anabolic androgenic steroid induced hypogonadism upon cessation among men (CloTASH) - a pilot study protocol. MethodsX. 2024;13: 102810.
</cite> [<a href="https://doi.org/10.1016/j.mex.2024.102810" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11253696/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39022178/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Havnes%20IA,%20Henriksen%20HCB,%20Johansen%20PW,%20Bj%C3%B8rnebekk%20A,%20Neupane%20SP,%20Hisdal%20J,%20et%20al.%20Off-label%20use%20of%20clomiphene%20citrate%20to%20treat%20anabolic%20androgenic%20steroid%20induced%20hypogonadism%20upon%20cessation%20among%20men%20(CloTASH)%20-%20a%20pilot%20study%20protocol.%20MethodsX.%202024;13:%20102810." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61">
<span class="label">61.</span><cite>Smit DL, Buijs MM, de Hon O, den Heijer M, de Ronde W. Disruption and recovery of testicular function during and after androgen abuse: the HAARLEM study. Hum Reprod. 2021;36(4):880–90.
</cite> [<a href="https://doi.org/10.1093/humrep/deaa366" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33550376/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Smit%20DL,%20Buijs%20MM,%20de%20Hon%20O,%20den%20Heijer%20M,%20de%20Ronde%20W.%20Disruption%20and%20recovery%20of%20testicular%20function%20during%20and%20after%20androgen%20abuse:%20the%20HAARLEM%20study.%20Hum%20Reprod.%202021;36(4):880%E2%80%9390." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR62">
<span class="label">62.</span><cite>Snyder PJ, Bauer DC, Ellenberg SS, Cauley JA, Buhr KA, Bhasin S, et al. Testosterone treatment and fractures in men with hypogonadism. N Engl J Med. 2024;390(3):203–11.
</cite> [<a href="https://doi.org/10.1056/NEJMoa2308836" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38231621/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Snyder%20PJ,%20Bauer%20DC,%20Ellenberg%20SS,%20Cauley%20JA,%20Buhr%20KA,%20Bhasin%20S,%20et%20al.%20Testosterone%20treatment%20and%20fractures%20in%20men%20with%20hypogonadism.%20N%20Engl%20J%20Med.%202024;390(3):203%E2%80%9311." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR63">
<span class="label">63.</span><cite>Bhasin S, Thompson IM. Prostate risk and monitoring during testosterone replacement therapy. J Clin Endocrinol Metab. 2024;109(8):1975–83.
</cite> [<a href="https://doi.org/10.1210/clinem/dgae334" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38753865/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bhasin%20S,%20Thompson%20IM.%20Prostate%20risk%20and%20monitoring%20during%20testosterone%20replacement%20therapy.%20J%20Clin%20Endocrinol%20Metab.%202024;109(8):1975%E2%80%9383." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR64">
<span class="label">64.</span><cite>Henriksen HCB, Jørgensen AP, Bjørnebekk A, Neupane SP, Havnes IA. Clomiphene citrate and optional human chorionic gonadotropin for treating male hypogonadism arising from long-term anabolic-androgenic steroid use—a pilot study. Performance Enhancement Health. 2024. 10.1016/j.peh.2024.100283.</cite> [<a href="https://scholar.google.com/scholar_lookup?Henriksen%20HCB,%20J%C3%B8rgensen%20AP,%20Bj%C3%B8rnebekk%20A,%20Neupane%20SP,%20Havnes%20IA.%20Clomiphene%20citrate%20and%20optional%20human%20chorionic%20gonadotropin%20for%20treating%20male%20hypogonadism%20arising%20from%20long-term%20anabolic-androgenic%20steroid%20use%E2%80%94a%20pilot%20study.%20Performance%20Enhancement%20Health.%202024.%2010.1016/j.peh.2024.100283." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR65">
<span class="label">65.</span><cite>Piatkowski T, Gibbs N, Dunn M. Beyond the law: on Etiocaasu, help-seeking and health outcomes in Australia. J Criminol. 2024;57:62–82. 10.1177/26338076231209044.</cite> [<a href="https://scholar.google.com/scholar_lookup?Piatkowski%20T,%20Gibbs%20N,%20Dunn%20M.%20Beyond%20the%20law:%20on%20Etiocaasu,%20help-seeking%20and%20health%20outcomes%20in%20Australia.%20J%20Criminol.%202024;57:62%E2%80%9382.%2010.1177/26338076231209044." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR66">
<span class="label">66.</span><cite>Dunn M, Piatkowski T, Whiteside B, Eu B. Exploring the experiences of general practitioners working with patients who use performance and image enhancing drugs. Perform Enhanc Health. 2023;11(2):100247. 10.1016/j.peh.2023.100247.</cite> [<a href="https://scholar.google.com/scholar_lookup?Dunn%20M,%20Piatkowski%20T,%20Whiteside%20B,%20Eu%20B.%20Exploring%20the%20experiences%20of%20general%20practitioners%20working%20with%20patients%20who%20use%20performance%20and%20image%20enhancing%20drugs.%20Perform%20Enhanc%20Health.%202023;11(2):100247.%2010.1016/j.peh.2023.100247." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR67">
<span class="label">67.</span><cite>Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D. The CARE guidelines: consensus-based clinical case reporting guideline development. Glob Adv Health Med. 2013;2(5):38–43.
</cite> [<a href="https://doi.org/10.7453/gahmj.2013.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3833570/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24416692/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gagnier%20JJ,%20Kienle%20G,%20Altman%20DG,%20Moher%20D,%20Sox%20H,%20Riley%20D.%20The%20CARE%20guidelines:%20consensus-based%20clinical%20case%20reporting%20guideline%20development.%20Glob%20Adv%20Health%20Med.%202013;2(5):38%E2%80%9343." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR68">
<span class="label">68.</span><cite>Seara FAC, Olivares EL, Nascimento JHM. Anabolic steroid excess and myocardial infarction: from ischemia to reperfusion injury. Steroids. 2020;161: 108660.
</cite> [<a href="https://doi.org/10.1016/j.steroids.2020.108660" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32492466/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Seara%20FAC,%20Olivares%20EL,%20Nascimento%20JHM.%20Anabolic%20steroid%20excess%20and%20myocardial%20infarction:%20from%20ischemia%20to%20reperfusion%20injury.%20Steroids.%202020;161:%20108660." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR69">
<span class="label">69.</span><cite>Liu JD, Wu YQ. Anabolic-androgenic steroids and cardiovascular risk. Chin Med J (Engl). 2019;132(18):2229–36.
</cite> [<a href="https://doi.org/10.1097/CM9.0000000000000407" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6797160/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31478927/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20JD,%20Wu%20YQ.%20Anabolic-androgenic%20steroids%20and%20cardiovascular%20risk.%20Chin%20Med%20J%20(Engl).%202019;132(18):2229%E2%80%9336." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR70">
<span class="label">70.</span><cite>Smit DL, Bond P, de Ronde W. Health effects of androgen abuse: a review of the HAARLEM study. Curr Opin Endocrinol Diabetes Obes. 2022;29(6):560–5.
</cite> [<a href="https://doi.org/10.1097/MED.0000000000000759" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35938779/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Smit%20DL,%20Bond%20P,%20de%20Ronde%20W.%20Health%20effects%20of%20androgen%20abuse:%20a%20review%20of%20the%20HAARLEM%20study.%20Curr%20Opin%20Endocrinol%20Diabetes%20Obes.%202022;29(6):560%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR71">
<span class="label">71.</span><cite>Bond P, Smit DL, de Ronde W. Anabolic-androgenic steroids: How do they work and what are the risks? Front Endocrinol (Lausanne). 2022;13:1059473.
</cite> [<a href="https://doi.org/10.3389/fendo.2022.1059473" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9837614/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36644692/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bond%20P,%20Smit%20DL,%20de%20Ronde%20W.%20Anabolic-androgenic%20steroids:%20How%20do%20they%20work%20and%20what%20are%20the%20risks?%20Front%20Endocrinol%20(Lausanne).%202022;13:1059473." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR72">
<span class="label">72.</span><cite>Gagnon LR, Sadasivan C, Perera K, Oudit GY. Cardiac complications of common drugs of abuse: pharmacology, toxicology, and management. Can J Cardiol. 2022;38(9):1331–41.
</cite> [<a href="https://doi.org/10.1016/j.cjca.2021.10.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34737034/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gagnon%20LR,%20Sadasivan%20C,%20Perera%20K,%20Oudit%20GY.%20Cardiac%20complications%20of%20common%20drugs%20of%20abuse:%20pharmacology,%20toxicology,%20and%20management.%20Can%20J%20Cardiol.%202022;38(9):1331%E2%80%9341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR73">
<span class="label">73.</span><cite>Ilonze OJ, Enyi CO, Ilonze CC. Cardiomyopathy and heart failure secondary to anabolic-androgen steroid abuse. Proc (Bayl Univ Med Cent). 2022;35(3):363–5.
</cite> [<a href="https://doi.org/10.1080/08998280.2022.2039496" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9037463/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35518797/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ilonze%20OJ,%20Enyi%20CO,%20Ilonze%20CC.%20Cardiomyopathy%20and%20heart%20failure%20secondary%20to%20anabolic-androgen%20steroid%20abuse.%20Proc%20(Bayl%20Univ%20Med%20Cent).%202022;35(3):363%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12369084/bin/12954_2025_1294_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1.</a><sup> (216.9KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The datasets supporting the conclusions of this article are included within the article and its additional files.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Harm Reduction Journal are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s12954-025-01294-w"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/12954_2025_Article_1294.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.4 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12369084/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12369084/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12369084%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369084/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12369084/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12369084/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40841640/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12369084/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40841640/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12369084/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12369084/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="4LSmnSf7S56YawA0R44W3JMyBMdsopQ6lZaqCifIn8FKaRqcFeGmHcLxkyOdVoCM">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
